Navigation Links
BCC Research Publishes a New Report on Global Markets for Influenza Products

Wellesley, MA (PRWEB) November 08, 2013

According to a new technical market research report, The Global Influenza Market from BCC Research (, the global market for influenza vaccines, antivirals, and diagnostic products was valued at nearly $3.8 billion in 2012 and is expected to reach $4 billion in 2013. BCC Research projects the market to grow to nearly $6 billion by 2018, and register a five-year compound annual growth rate (CAGR) of 8% from 2013 to 2018.

Influenza, also known as the flu, affects the upper respiratory tract and often the lungs. The infection typically lasts approximately one week, but without the use of medications the virus can continue to cause symptoms for two weeks or more. The most typical method of transmission is by moisture droplets being spread by coughing and sneezing. The young and the elderly are considered to be at a higher risk primarily due to the vulnerable state of their immune system. People with chronic diseases, such as cancer and HIV, are also at a higher risk; for them, contracting influenza can be deadly.

Annually, up to a half-million people die of influenza, and with the threat of a pandemic in any given year, government agencies and disease prevention organizations are devoted to gaining control of the situation. The 2009 pandemic generated attention to surveillance measures, pandemic preparedness, vaccine production, and antiviral control. It also revealed issues with laboratory capacity and the benefits of rapid testing in a pandemic situation.

Many companies have been asked to assist with the problem and others are furthering their position with backing from government agencies. According to BCC Research, the next five years will continue to display support and funding for many research and development programs, product development, and pandemic prevention and/or control by worldwide governments, organizations, and health professionals.

The influenza products market can be broken down into three segments, including vaccines, therapeutics, and diagnostics. All three segments are significantly impacted by seasonal factors and will be vulnerable to weak flu seasons. However, increased efforts in education for preventing influenza through vaccine use will continue to be beneficial to vaccine product developers/marketers. Several significant trends continue to influence the global influenza market including H1N1 outbreaks, Avian Flu surveillance, antiviral resistance, recreated viruses, cell-based and recombinant products, epidemic/pandemic preparedness, immaterialized market risk, and world influenza impact (seasonal and pandemic).

An aging population is a significant driver in the growth of the market, boosting sales for products directed at preventive measures, while the international market continues to show promise in vaccination, treatment, and diagnosis.

This BCC Research report is designed to be a helpful business tool that provides a thorough evaluation of the market for influenza products. The geographic scope of this study is worldwide, with emphasis on U.S. and European data. The report identifies markets in general segments: vaccines/therapeutics and diagnostics. Each market segment discussion provides detailed information based on product categories, uses of products, forecasts, and competitive analyses. Additionally, the study covers some of the most significant issues, trends, and market factors.


Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Researchers at Pace University Explore the Lived Experiences of Families Members That Have the Possible Risk of Genetic Mutations That Cause Sudden Cardiac Death
2. Global In Vitro Fertilization Market 2012-2016 New Research Report at
3. Lip Balm for Chapped Lips Often Incorrectly Applied Reports Water and Health Researcher
4. Dartmouth researcher finds novel genetic patterns that make us rethink biology and individuality
5. UT Southwestern researchers discover a new driver of breast cancer
6. NYC Injury Lawyers Block O'Toole & Murphy Hosted Their 2013 Autumn Wine Tasting Event To Benefit St. Jude Children's Research Hospital And It Was A Huge Success
7. New report calls for sustained public endorsement and funding for human stem cell research
8. Research and Development Forecast of China’s Water Purifier Industry, 2013-2017
9. The Global UAV Market 2013–2023 – New Research Available
10. Global Compression Therapy Market 2012-2016: Worldwide Industry Share, Investment Trends, Growth, Size, Strategy And Forecast Research Report
11. Sanders-Brown researchers produce new research on little-understood brain disease
Post Your Comments:
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from reveals that behind the tendency to set ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
(Date:6/24/2016)... New York, NY (PRWEB) , ... June 24, ... ... lifestyle publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as ... believes that “the most beautiful women in the world, and the most handsome ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... -- , , , WHEN: , ... , , , LOCATION: , , , Online, with free ... EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice President ... Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... is witnessing an exceptional era. Several new demand spaces, such as ...
Breaking Medicine Technology: